EPISTAR CORPORATION – Trademark Portfolio
Entity Type: 03
EPISTAR CORPORATION holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 18 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include MARS, VENUS, EPISTAR, EPISTAR LAB, and CO-ACTIVATION. The owner is based in HSINCHU.
No. 5, Li-Hsin Road V, S. B. I. P
HSINCHU 300 , TW
Showing of trademarks Trademarks
Trademark Classifications
EPISTAR CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does EPISTAR CORPORATION have?
EPISTAR CORPORATION has 23 U.S. trademarks filed with the USPTO. Of these, 7 registered, 6 abandoned, 10 cancelled.
What trademark classes does EPISTAR CORPORATION file in?
EPISTAR CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are EPISTAR CORPORATION's most well-known trademarks?
EPISTAR CORPORATION's registered trademark portfolio includes well-known marks such as MARS, VENUS, EPISTAR, EPISTAR LAB, and CO-ACTIVATION. These are among 7 currently registered trademarks in the portfolio.
What is EPISTAR CORPORATION's trademark registration success rate?
EPISTAR CORPORATION has a 30% trademark registration rate, with 7 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.